Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

NCT03856697 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG: Abivertinib Maleate Capsules
DRUG: Placebo Gefitinib Tablets
DRUG: Gefitinib Tablets
DRUG: Placebo Abivertinib Maleate Capsules

Sponsor

Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Collaborators

[object Object]